alcoholic liver cirrhosis
alcoholic liver cirrhosis
Explore linked clinical trials. Standard reference: MONDO:000664413 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States | Chemically-Induced Disorders, Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, alcohol-induced disorders, alcohol-related disorders, alcoholic liver cirrhosis, alcoholic liver disease, cirrhosis of liver, fatty liver disease, liver disorder, metabolic dysfunction-associated steatotic liver disease, substance-related disorder | Recruiting | Phase 2 | 2026-09-28 | NCT05832229 | |
| A-TANGO Phase 2 Study | Acute-On-Chronic Liver Failure, Chemically-Induced Disorders, Digestive System Diseases, Fibrosis, Hepatic Insufficiency, Pathologic Processes, Pathological Conditions, Signs and Symptoms, acute liver failure, alcohol-induced disorders, alcohol-related disorders, alcoholic hepatitis, alcoholic liver cirrhosis, alcoholic liver disease, cirrhosis of liver, hepatitis, liver disorder, liver failure, substance-related disorder | Recruiting | Phase 2 | 2026-09-21 | NCT06890039 | |
| Long-Term Follow-up of Patients With Alcoholic Liver Cirrhosis Treated With Cellgram-LC | Chemically-Induced Disorders, Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, alcohol-induced disorders, alcohol-related disorders, alcoholic liver cirrhosis, alcoholic liver disease, cirrhosis of liver, liver disorder, substance-related disorder | Recruiting | Not stated | 2026-09-21 | NCT05093881 | |
| Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic Cirrhosis | Chemically-Induced Disorders, Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, alcohol-induced disorders, alcohol-related disorders, alcoholic liver cirrhosis, alcoholic liver disease, cirrhosis of liver, liver disorder, substance-related disorder | Recruiting | Phase 3 | 2026-09-21 | NCT04689152 | |
| Acquisition of Cardiac Function Parameters in MRI and Echocardiography in Patients With Ethyltoxic Liver Cirrhosis and Transjugular Intrahepatic Portosystemic Shunt (TIPSS) Placement | Chemically-Induced Disorders, Digestive System Diseases, Fibrosis, Heart Decompensation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, alcohol-induced disorders, alcohol-related disorders, alcoholic liver cirrhosis, alcoholic liver disease, cardiovascular disorder, cirrhosis of liver, heart disorder, heart failure, liver disorder, metabolic dysfunction-associated steatotic liver disease, substance-related disorder | Recruiting | Not applicable | 2026-08-04 | NCT06814990 | |
| Pomegranate Dietary Supplements in AUD and ALD | Alcohol Use Disorder, Chemically-Induced Disorders, Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, alcohol-induced disorders, alcohol-related disorders, alcoholic liver cirrhosis, alcoholic liver disease, cirrhosis of liver, liver disorder, psychiatric disorder, substance-related disorder | Not yet recruiting | Not stated | 2026-07-24 | NCT07678567 | |
| Study of Genetic Determinants in Alcoholic Hepatitis and Establishment of a Multicenter Prospective Cohort of Patients With Alcoholic Liver Disease | Chemically-Induced Disorders, Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, alcohol-induced disorders, alcohol-related disorders, alcoholic hepatitis, alcoholic liver cirrhosis, alcoholic liver disease, cirrhosis of liver, hepatitis, liver disorder, substance-related disorder | Recruiting | Not stated | 2026-05-19 | NCT04106518 | |
| SAMe Trial for Patients With Alcoholic Cirrhosis | Chemically-Induced Disorders, Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, alcohol-induced disorders, alcohol-related disorders, alcoholic liver cirrhosis, alcoholic liver disease, cirrhosis of liver, liver disorder, substance-related disorder | Recruiting | Phase 2 | 2026-03-31 | NCT04250259 | |
| Financial Rewards for Reducing Alcohol Use in Patients With Liver Disease | Alcohol Use Disorder, Chemically-Induced Disorders, Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, alcohol-induced disorders, alcohol-related disorders, alcoholic liver cirrhosis, alcoholic liver disease, cirrhosis of liver, liver disorder, psychiatric disorder, substance-related disorder | Not yet recruiting | Not applicable | 2026-03-12 | NCT07465588 | |
| Liver Cirrhosis Network Cohort Study | Chemically-Induced Disorders, Cirrhosis, Cryptogenic, Digestive System Diseases, Fibrosis, Hepatitis, Chronic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, alcohol-induced disorders, alcohol-related disorders, alcoholic liver cirrhosis, alcoholic liver disease, autoimmune disease, autoimmune hepatitis, bile duct disorder, biliary tract disorder, cholestasis, cirrhosis of liver, fatty liver disease, hepatitis, immune system disorder, intrahepatic cholestasis, liver disorder, metabolic dysfunction-associated steatotic liver disease, primary biliary cholangitis, substance-related disorder | Active, not recruiting | Not stated | 2026-01-13 | NCT05740358 | |
| Optimized Remission in Alcohol-related Liver Cirrhosis | Chemically-Induced Disorders, Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, alcohol-induced disorders, alcohol-related disorders, alcoholic liver cirrhosis, alcoholic liver disease, cirrhosis of liver, liver disorder, substance-related disorder | Recruiting | Not applicable | 2025-03-10 | NCT06866496 | |
| Safety & Efficacy of Baclofen for Alcohol Withdrawal in Chronic Liver Disease With Active Alcohol Consumption | Chemically-Induced Disorders, Digestive System Diseases, Drug-Related Side Effects and Adverse Reactions, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, alcohol withdrawal, alcohol-induced disorders, alcohol-related disorders, alcoholic liver cirrhosis, alcoholic liver disease, cirrhosis of liver, liver disorder, substance-related disorder | Enrolling by invitation | Not stated | 2025-02-21 | NCT06840652 | |
| Profermin®: Prevention of Progression in Alcoholic Liver Disease by Modulating Dysbiotic Microbiota | Chemically-Induced Disorders, Digestive System Diseases, Fibrosis, Fibrosis, Liver, Pathologic Processes, Pathological Conditions, Signs and Symptoms, alcohol-induced disorders, alcohol-related disorders, alcoholic liver cirrhosis, alcoholic liver disease, cirrhosis of liver, liver disorder, substance-related disorder | Active, not recruiting | Not applicable | 2023-11-07 | NCT03863730 |